Back to GEN Stock Lookup
Pages: 1 2 »» Last Page

Genon Energy (GEN) – Company Press Releases

Feb 10, 2016 02:32 PM Genesis Healthcare Raises Nearly $255,000 As Gold National Team For Alzheimer's Association Walk To End Alzheimer's®
Feb 4, 2016 06:32 PM Major Shareholder Announcement
Feb 4, 2016 10:48 AM New hospitals and health care providers join successful, cutting-edge federal initiative that cuts costs and puts patients at the center of their care
Feb 2, 2016 01:00 AM Medicxi Ventures, Formerly Index Ventures Life Sciences, Launches as an Independent Venture Capital Firm and Announces Closing of a €210m Fund including GSK and Johnson & Johnson Innovation
Jan 25, 2016 08:30 AM Genesis Healthcare Announces Preliminary 2016 Growth Outlook And Adjusts 2015 Guidance
Jan 19, 2016 03:25 PM Genmab Announces U.S. FDA Approval of Arzerra(r) (ofatumumab) as Extended Treatment for Recurrent or Progressive CLL
Jan 18, 2016 04:45 PM GeneNews Announces Notification of TSX Continued Listing Review
Jan 11, 2016 04:13 PM Genesis Rehab Services and Apollo Education Group to Accelerate Health Care Workforce Training in China
Jan 4, 2016 08:30 AM Genesis HealthCare Divests Vintage Park Assisted Living Properties In Kansas
Dec 21, 2015 12:08 PM Genmab Achieves $3 Million Milestone in DuoBody Platform Collaboration with Janssen
Dec 18, 2015 09:08 AM Genmab Achieves $3 Million Milestone for Progress in DuoBody Platform Collaboration with Janssen
Dec 9, 2015 09:56 AM Genmab Achieves USD 5 Million Milestone in Daratumumab Collaboration with Janssen
Dec 7, 2015 08:00 AM GeneNews Provides Further Corporate Update
Dec 7, 2015 08:00 AM GeneNews Provides Further Corporate Update
Dec 3, 2015 10:42 AM Genesis HealthCare to Present at Oppenheimer's 26th Annual Healthcare Conference
Dec 1, 2015 12:28 PM Genesis HealthCare Completes Previously Announced Transaction With Revera Inc.
Nov 23, 2015 05:08 PM Genmab Announces Ofatumumab Phase III Study in Follicular Lymphoma to be Stopped Following Planned Interim Analysis
Nov 19, 2015 06:14 PM Genmab Achieves USD 45 Million Milestone in DARZALEX(TM) (daratumumab) Collaboration With Janssen
Nov 17, 2015 11:38 AM Major Shareholder Announcement
Nov 16, 2015 02:29 PM Genmab Announces U.S. FDA Approval of DARZALEX(TM) (daratumumab) for Multiple Myeloma and Updates Financial Guidance
Nov 13, 2015 08:30 AM GeneNews Announces Q3-2015 Financial Results and Provides Update
Nov 12, 2015 08:30 AM Genesis HealthCare Announces Value-Based Initiatives
Nov 9, 2015 04:46 PM Genesis HealthCare to Present at the Stephens Fall Investment Conference on November 10, 2015
Nov 5, 2015 04:03 PM Genesis HealthCare Reports Third Quarter 2015 Results
Nov 5, 2015 04:03 PM Genesis HealthCare Reports Third Quarter 2015 Results
Nov 3, 2015 11:09 AM Genmab Announces Financial Results for the First Nine Months of 2015 and Improves 2015 Financial Guidance
Oct 25, 2015 05:44 PM Genmab Achieves $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen
Oct 23, 2015 09:36 AM Major shareholder announcement for Genmab A/S
Oct 22, 2015 08:30 AM Genesis HealthCare Receives HUD Corporate Portfolio Credit Approval
Oct 21, 2015 11:17 AM Genesis HealthCare To Release Third Quarter 2015 Results On November 5, 2015
Oct 16, 2015 10:19 AM Major Shareholder Announcement
Oct 8, 2015 12:01 PM Major Shareholder Announcement
Oct 5, 2015 09:51 AM Genmab Reaches $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen
Sep 29, 2015 11:38 AM Major Shareholder Announcement
Sep 25, 2015 05:14 AM CHMP Grants Accelerated Assessment for Daratumumab for Double Refractory Multiple Myeloma
Sep 19, 2015 09:49 AM U.S. FDA Grants Priority Review for Ofatumumab as Maintenance Therapy for Relapsed CLL
Sep 9, 2015 07:38 AM Genmab Announces European Regulatory Submission for Daratumumab in Double Refractory Multiple Myeloma
Sep 8, 2015 08:06 AM Promising Early Results of 10,000 Patient Lung Cancer Screening Trial Using EarlyCDT(R)-Lung Blood Test Announced at WCLC 2015
Sep 8, 2015 08:06 AM Promising Early Results of 10,000 Patient Lung Cancer Screening Trial Using EarlyCDT(R)-Lung Blood Test Announced at WCLC 2015
Sep 4, 2015 02:25 PM U.S. FDA Grants Priority Review for Daratumumab for Double Refractory Multiple Myeloma
Sep 3, 2015 04:15 PM GeneNews' Innovative Diagnostic Laboratory J-V to Provide PHI Testing Services to MD Anderson Cancer Center
Sep 3, 2015 04:15 PM GeneNews' Innovative Diagnostic Laboratory J-V to Provide PHI Testing Services to MD Anderson Cancer Center
Sep 2, 2015 04:14 PM Major Shareholder Announcement
Aug 27, 2015 01:35 AM Data Published in The New England Journal of Medicine Shows Daratumumab Monotherapy Induced Durable Responses in Heavily Pre-treated Relapsed or Refractory Multiple Myeloma Patients
Aug 24, 2015 07:00 AM Skies Healthcare and Rehabilitation Center Earns Top Distinction in Quality Care
Aug 14, 2015 07:45 AM GeneNews Announces Q2-2015 Financial Results & Provides IDL Progress Update
Aug 14, 2015 07:45 AM GeneNews Announces Q2-2015 Financial Results & Provides IDL Progress Update
Aug 14, 2015 06:37 AM Genmab Enters Commercial License Agreement with Novo Nordisk for DuoBody Technology
Aug 12, 2015 01:59 AM Genmab Announces Financial Results for the First Half of 2015
Aug 6, 2015 05:29 PM Genesis HealthCare Reports Second Quarter 2015 Results
Pages: 1 2 »» Last Page

Back to GEN Stock Lookup